Skip to main content
Homepage of ProQR
  • We are ProQR
    • About ProQR Therapeutics
    • Founding story
    • Leadership
    • Careers
      • Vacancies
    • Contact
    • Events
  • Science & Pipeline
    • Pipeline
      • Sepofarsen (CEP290 LCA10)
      • QR-421a (USH2A RP)
      • QR-1123 (RHO RP)
    • Presentations & Publications
    • RNA therapy
      • Axiomer technology
  • Patients & Community
    • Blogs, Stories & News
    • What is a clinical trial?
      • Illuminate Ph2/3 trial (CEP290 LCA10)
      • Stellar Ph1/2 trial (USH2A RP)
      • Aurora Ph1/2 trial (RHO RP)
    • Inherited retinal diseases
      • Leber congenital amaurosis
      • Retinitis pigmentosa
      • Usher syndrome
    • The importance of genetic testing
      • My Retina Tracker program
    • Eye Connect newsletter
    • Expanded access policy
  • Health Professionals
    • Clinical research
    • Educational content
    • Events
    • Expert Eyes newsletter
    • Expert Perspectives series
  • Investors & Media
    • Press Releases
    • Events
    • Email alerts
    • Corporate presentation
    • Share performance
    • Financial information
    • Corporate governance
    • Analysts
Home

Shareholder meetings archive

Jump to section

2019 AGM

2019 AGM

  • AGM 2019 Minutes.pdf pdf, 387.89 KB
  • AGM 2019 Notice and Agenda.pdf pdf, 365.57 KB
  • AGM 2019 Explanatory Notes.pdf pdf, 315.22 KB
  • AGM 2019 Compensation Principles SB.pdf pdf, 299.87 KB
  • AGM 2019 Compensation Policy MB.pdf pdf, 298.76 KB
  • AGM 2019 Proxy Registered Holders.pdf pdf, 82.25 KB
2018 AGM

2018 AGM

  • AGM 2018 minutes.pdf pdf, 388.57 KB
  • AGM 2018 Notice and agenda.pdf pdf, 330.54 KB
  • AGM 2018 Explanatory notes.pdf pdf, 286.51 KB
  • AGM 2018 Proxy Registered Holders.pdf pdf, 82.76 KB
2018 EGM

2018 EGM

  • EGM 2018 minutes.pdf pdf, 453.85 KB
  • EGM 2018 Notice and agenda.pdf pdf, 329.53 KB
  • EGM 2018 Explanatory notes.pdf pdf, 261.08 KB
  • EGM 2018 Proposed_amendments_articles_redline_EN.pdf pdf, 212.51 KB
  • EGM 2018 Proposed_amendments_articles_redline_NL.pdf pdf, 202.71 KB
  • EGM 2018 Proxy registered holders.pdf pdf, 72.05 KB
2017 AGM

2017 AGM

  • AGM 2017 Minutes.pdf pdf, 356.13 KB
  • AGM 2017 Notice and Agenda.pdf pdf, 328.7 KB
  • AGM 2017 Explanatory notes.pdf pdf, 279.24 KB
  • AGM 2017 Proxy registered holders.pdf pdf, 79.65 KB
2016 AGM

2016 AGM

  • AGM 2016 Minutes.pdf pdf, 157.47 KB
  • AGM 2016 Notice and agenda.pdf pdf, 205.63 KB
  • AGM 2016 Explanatory notes.pdf pdf, 333.98 KB
  • AGM 2016 Proposal amendment articles of association - Dutch.pdf pdf, 12.97 KB
  • AGM 2016 Proposal amendment articles of association - English.pdf pdf, 143.58 KB
  • AGM 2016 Amended Compensation Policy Management Board.pdf pdf, 192.99 KB
  • AGM 2016 Amended Compensation Principles Supervisory Board.pdf pdf, 149.78 KB
  • AGM 2016 Proxy registered shareholders.pdf pdf, 176.38 KB
2015 AGM

2015 AGM

  • AGM 2015 Minutes.pdf pdf, 178.09 KB
  • AGM 2015 Notice and agenda.pdf pdf, 105.54 KB
  • AGM 2015 Explanatory notes.pdf pdf, 53.81 KB
  • AGM 2015 Amended Compensation Principles.pdf pdf, 177.11 KB
  • Demerger proposal ProQR Therapeutics N.V..pdf pdf, 97.37 KB
  • Annex A current Articles of association.pdf pdf, 179.62 KB
  • Annex B Demerger Proposal.pdf pdf, 163.24 KB
  • Annex C Description Demerger Proposal.pdf pdf, 200.01 KB
  • Annex D & E Pro forma Profit & Loss Accounts.pdf pdf, 307.78 KB

Follow us:

  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
  • SoundCloud
  • Contact
  • Disclaimer
  • Privacy
© 2021 ProQR Therapeutics. All Rights Reserved.